Skip to main content
Erschienen in: Supportive Care in Cancer 8/2011

01.08.2011 | Original Article

Views of psycho-oncology health professionals on priority psycho-oncology research questions

verfasst von: Nicole M. Rankin, Phyllis N. Butow, Melanie A. Price, Alison Evans

Erschienen in: Supportive Care in Cancer | Ausgabe 8/2011

Einloggen, um Zugang zu erhalten

Abstract

Purpose

There is a need for periodic review of research priorities in psycho-oncology. The purpose of this research was to conduct a qualitative study designed to canvass the views of health professionals working in psycho-oncology in Australia regarding current priority areas for research in psycho-oncology.

Methods

This study was conducted in two phases. This article reports the results from the first phase, where focus groups were conducted with key researchers and clinicians active in psycho-oncology.

Results

A total of 55 individuals took part in ten focus groups and two interviews. Participants identified 12 priority areas for research. These areas were grouped into four global themes given a significant overlap in the research issues identified. The four global themes are: distress—improving identification, detection, referral and management; specific populations requiring intervention research; the patient journey; and health services research. Key issues identified for each theme are documented along with participant quotes.

Conclusions

This research provides the first steps in identifying research priorities in psycho-oncology and will guide the development of pertinent research studies as well as inform collaborative research studies focusing on clinically relevant interventions. The outcomes of such studies should ultimately guide optimal patient care.
Literatur
1.
Zurück zum Zitat Holland JC (2002) History of psycho-oncology: overcoming attitudinal and conceptual barriers. Psychosom Med 64:206–211PubMed Holland JC (2002) History of psycho-oncology: overcoming attitudinal and conceptual barriers. Psychosom Med 64:206–211PubMed
2.
Zurück zum Zitat Kock U (2008) IPOS Sutherland Memorial Lecture: psycho-oncology and health care research. Psycho Oncology 17:533–537CrossRef Kock U (2008) IPOS Sutherland Memorial Lecture: psycho-oncology and health care research. Psycho Oncology 17:533–537CrossRef
3.
Zurück zum Zitat Nehl EJ, Blanchard CM, Stafford JS, Ainsworth S, Baker F (2003) Research interests in the field of behavioral, psychosocial, and policy cancer research. Psycho Oncology 12:385–392PubMedCrossRef Nehl EJ, Blanchard CM, Stafford JS, Ainsworth S, Baker F (2003) Research interests in the field of behavioral, psychosocial, and policy cancer research. Psycho Oncology 12:385–392PubMedCrossRef
4.
Zurück zum Zitat Massie MJ, Holland JC (1984) Diagnosis and treatment of depression in the cancer patient. J Clin Psychiatry 45:25–28PubMed Massie MJ, Holland JC (1984) Diagnosis and treatment of depression in the cancer patient. J Clin Psychiatry 45:25–28PubMed
5.
Zurück zum Zitat Zabora J, Brintzenhofeszoc K, Curbow B, Hooker C, Piantadosi S (2001) The prevalence of psychological distress by cancer site. Psycho Oncology 10:19–28PubMedCrossRef Zabora J, Brintzenhofeszoc K, Curbow B, Hooker C, Piantadosi S (2001) The prevalence of psychological distress by cancer site. Psycho Oncology 10:19–28PubMedCrossRef
6.
Zurück zum Zitat Parle M, Jones B, Maguire P (1996) Maladaptive coping and affective disorders among cancer patients. Psych Med 26:35–744CrossRef Parle M, Jones B, Maguire P (1996) Maladaptive coping and affective disorders among cancer patients. Psych Med 26:35–744CrossRef
7.
Zurück zum Zitat Parle M, Maguire P (1995) Exploring relationships between cancer, coping, and mental health. J Psychosoc Oncol 13:27–50CrossRef Parle M, Maguire P (1995) Exploring relationships between cancer, coping, and mental health. J Psychosoc Oncol 13:27–50CrossRef
8.
Zurück zum Zitat Weisman AD, Worden JW (1976) The existential plight in cancer: significance of the first 100 days. Int J Psychiatry Med 7:1–15PubMedCrossRef Weisman AD, Worden JW (1976) The existential plight in cancer: significance of the first 100 days. Int J Psychiatry Med 7:1–15PubMedCrossRef
9.
Zurück zum Zitat Given CW, Stommel M, Given B, Osuch J, Kurtz ME, Kurtz JC (1993) The influence of cancer patient symptoms functional states on patient depression and family caregiver reaction and depression. Health Psychol 12:277–285PubMedCrossRef Given CW, Stommel M, Given B, Osuch J, Kurtz ME, Kurtz JC (1993) The influence of cancer patient symptoms functional states on patient depression and family caregiver reaction and depression. Health Psychol 12:277–285PubMedCrossRef
10.
Zurück zum Zitat Sanson-Fisher R, Girgis A, Boyes A, Bonevski B, Burton L, Cook P, the Supportive Care Review Group (2000) The unmet supportive care needs of patients with cancer. Cancer 88:226–237PubMedCrossRef Sanson-Fisher R, Girgis A, Boyes A, Bonevski B, Burton L, Cook P, the Supportive Care Review Group (2000) The unmet supportive care needs of patients with cancer. Cancer 88:226–237PubMedCrossRef
11.
Zurück zum Zitat de Haes JC et al (1985) The quality of life of cancer patients: a review of the literature. Soc Sci Med 20:809–817PubMedCrossRef de Haes JC et al (1985) The quality of life of cancer patients: a review of the literature. Soc Sci Med 20:809–817PubMedCrossRef
12.
13.
Zurück zum Zitat National Breast Cancer Centre and National Cancer Control Initiative (2003) Clinical practice guidelines for the psychosocial care of adults with cancer. National Breast Cancer Centre, Camperdown National Breast Cancer Centre and National Cancer Control Initiative (2003) Clinical practice guidelines for the psychosocial care of adults with cancer. National Breast Cancer Centre, Camperdown
14.
Zurück zum Zitat Turner J, Zapart S, Pedersen K, Rankin N, Luxford K, Fletcher J (2005) Clinical practice guidelines for the psychosocial care of adults with cancer. Psycho Oncology 14:159–173PubMedCrossRef Turner J, Zapart S, Pedersen K, Rankin N, Luxford K, Fletcher J (2005) Clinical practice guidelines for the psychosocial care of adults with cancer. Psycho Oncology 14:159–173PubMedCrossRef
15.
Zurück zum Zitat National Comprehensive Cancer Network (2002) Practice guidelines in oncology—v. 1.2002: Distress management: National Comprehensive Cancer Network. National Comprehensive Cancer Network (2002) Practice guidelines in oncology—v. 1.2002: Distress management: National Comprehensive Cancer Network.
16.
Zurück zum Zitat Canadian Association of Psychosocial Oncology (1999) National psychosocial oncology standards for Canada. Canadian Association of Psychosocial Oncology, Montreal, Canada Canadian Association of Psychosocial Oncology (1999) National psychosocial oncology standards for Canada. Canadian Association of Psychosocial Oncology, Montreal, Canada
17.
Zurück zum Zitat National Health Priority Action Council (2006) National Service Improvement Framework for Cancer. Australian Government Department of Health and Ageing, Canberra, Australia National Health Priority Action Council (2006) National Service Improvement Framework for Cancer. Australian Government Department of Health and Ageing, Canberra, Australia
18.
Zurück zum Zitat Butow P, Hagerty R (2006) The Psycho-oncology Co-operative Research Group. Cancer Forum 34(5):42–44 Butow P, Hagerty R (2006) The Psycho-oncology Co-operative Research Group. Cancer Forum 34(5):42–44
19.
Zurück zum Zitat Carlson LE, Bultz BD (2004) Efficacy and medical cost offset of psychosocial interventions in cancer care: making the case for economic analyses. Psycho Oncology 13:837–849PubMedCrossRef Carlson LE, Bultz BD (2004) Efficacy and medical cost offset of psychosocial interventions in cancer care: making the case for economic analyses. Psycho Oncology 13:837–849PubMedCrossRef
20.
Zurück zum Zitat Kerr D, Bevan H, Gowland B, Penny J, Berwick D (2002) Redesigning cancer care. BMJ 324:164–166PubMedCrossRef Kerr D, Bevan H, Gowland B, Penny J, Berwick D (2002) Redesigning cancer care. BMJ 324:164–166PubMedCrossRef
21.
Zurück zum Zitat Yates P (2004) Cancer care coordinators: realising the potential for improving the patient journey. Cancer Forum 28(3):129–132 Yates P (2004) Cancer care coordinators: realising the potential for improving the patient journey. Cancer Forum 28(3):129–132
22.
Zurück zum Zitat Farquhar MC, Barclay SIG, Earl H, Grande GF, Emery J, Crawford RAF (2005) Barriers to effective communication across the primary/secondary interface: examples from the ovarian cancer patient journey (a qualitative study). Eur J Cancer Care 14:359–366CrossRef Farquhar MC, Barclay SIG, Earl H, Grande GF, Emery J, Crawford RAF (2005) Barriers to effective communication across the primary/secondary interface: examples from the ovarian cancer patient journey (a qualitative study). Eur J Cancer Care 14:359–366CrossRef
23.
Zurück zum Zitat Rankin N, Newell S, Sanson-Fisher R, Girgis A (2000) Consumer participation in the development of psychosocial clinical practice guidelines: opinions of women with breast cancer. Eur J Cancer Care 9(2):97–104CrossRef Rankin N, Newell S, Sanson-Fisher R, Girgis A (2000) Consumer participation in the development of psychosocial clinical practice guidelines: opinions of women with breast cancer. Eur J Cancer Care 9(2):97–104CrossRef
Metadaten
Titel
Views of psycho-oncology health professionals on priority psycho-oncology research questions
verfasst von
Nicole M. Rankin
Phyllis N. Butow
Melanie A. Price
Alison Evans
Publikationsdatum
01.08.2011
Verlag
Springer-Verlag
Erschienen in
Supportive Care in Cancer / Ausgabe 8/2011
Print ISSN: 0941-4355
Elektronische ISSN: 1433-7339
DOI
https://doi.org/10.1007/s00520-010-0922-x

Weitere Artikel der Ausgabe 8/2011

Supportive Care in Cancer 8/2011 Zur Ausgabe

Adjuvante Immuntherapie verlängert Leben bei RCC

25.04.2024 Nierenkarzinom Nachrichten

Nun gibt es auch Resultate zum Gesamtüberleben: Eine adjuvante Pembrolizumab-Therapie konnte in einer Phase-3-Studie das Leben von Menschen mit Nierenzellkarzinom deutlich verlängern. Die Sterberate war im Vergleich zu Placebo um 38% geringer.

Alectinib verbessert krankheitsfreies Überleben bei ALK-positivem NSCLC

25.04.2024 NSCLC Nachrichten

Das Risiko für Rezidiv oder Tod von Patienten und Patientinnen mit reseziertem ALK-positivem NSCLC ist unter einer adjuvanten Therapie mit dem Tyrosinkinase-Inhibitor Alectinib signifikant geringer als unter platinbasierter Chemotherapie.

Bei Senioren mit Prostatakarzinom auf Anämie achten!

24.04.2024 DGIM 2024 Nachrichten

Patienten, die zur Behandlung ihres Prostatakarzinoms eine Androgendeprivationstherapie erhalten, entwickeln nicht selten eine Anämie. Wer ältere Patienten internistisch mitbetreut, sollte auf diese Nebenwirkung achten.

ICI-Therapie in der Schwangerschaft wird gut toleriert

Müssen sich Schwangere einer Krebstherapie unterziehen, rufen Immuncheckpointinhibitoren offenbar nicht mehr unerwünschte Wirkungen hervor als andere Mittel gegen Krebs.

Update Onkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.